Jackson Grant Investment Advisers’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.19K Hold
225
﹤0.01% 345
2026
Q1
$8.38K Hold
225
﹤0.01% 314
2025
Q4
$10.5K Hold
225
﹤0.01% 297
2025
Q3
$9.43K Hold
225
﹤0.01% 300
2025
Q2
$9.9K Hold
225
﹤0.01% 267
2025
Q1
$11.3K Hold
225
﹤0.01% 259
2024
Q4
$9.66K Hold
225
﹤0.01% 266
2024
Q3
$8.82K Hold
225
﹤0.01% 272
2024
Q2
$7.24K Hold
225
﹤0.01% 284
2024
Q1
$7.41K Sell
225
-25
-10% -$869 ﹤0.01% 272
2023
Q4
$8.68K Sell
250
-213
-46% -$7.35K ﹤0.01% 259
2023
Q3
$16.8K Hold
463
0.01% 228
2023
Q2
$17.4K Hold
463
0.01% 232
2023
Q1
$21.4K Buy
463
+25
+6% +$1.17K 0.01% 254
2022
Q4
$20.3K Hold
438
0.01% 253
2022
Q3
$19K Hold
438
0.01% 260
2022
Q2
$19K Hold
438
0.01% 267
2022
Q1
$19K Hold
438
0.01% 287
2021
Q4
$23K Hold
438
0.01% 227
2021
Q3
$21K Hold
438
0.01% 283
2021
Q2
$20K Buy
438
+28
+7% +$1.27K 0.01% 297
2021
Q1
$18K Buy
+410
New +$17K 0.01% 300

Other funds holding G

Jackson Grant Investment Advisers's G Position: Q2 2026 in Review

Jackson Grant Investment Advisers held its Genpact (G) position steady in Q2 2026 at 225 shares worth $6.19K. The position accounts for ﹤0.01% of the portfolio, ranked #345.

Jackson Grant Investment Advisers first reported a position in G in Q1 2021 and has held it in 22 quarters since. The position peaked at $23K in Q4 2021. 144 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Jackson Grant Investment Advisers held 225 shares of Genpact worth $6.19K as of Q2 2026.
  • Jackson Grant Investment Advisers left its Genpact share count unchanged in Q2 2026.
  • Genpact made up ﹤0.01% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #345 holding.
  • Jackson Grant Investment Advisers first reported a position in Genpact in Q1 2021 and has held it in 22 quarters since.
  • Jackson Grant Investment Advisers's Genpact position peaked at $23K in Q4 2021.
  • 144 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.